Salipro Biotech and Icosagen Launch Antibody Discovery Collaboration
Salipro Biotech and Icosagen announce the initiation of a multi-target collaboration for the discovery and characterization of monoclonal antibodies against several GPCRs and SLC transporters.Stockholm, Sweden and Tartu, Estonia, October 10, 2023 – Swedish biotech company Salipro Biotech AB and Estonian biotechnology company Icosagen today announced that they entered into a multi-target antibody research agreement to advance drug discovery programs against several challenging membrane proteins, including G protein-coupled receptors (GPCRs) and solute carrier (SLC) transporters. The